Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct;62(12):835-842.
doi: 10.1002/jlcr.3791. Epub 2019 Aug 8.

Improved synthesis of 4-[18 F]fluoro-m-hydroxyphenethylguanidine using an iodonium ylide precursor

Yong-Woon Jung  1 , Guie Gu  1 , David M Raffel  1
Affiliations
Free article

Improved synthesis of 4-[18 F]fluoro-m-hydroxyphenethylguanidine using an iodonium ylide precursor

Yong-Woon Jung et al. J Labelled Comp Radiopharm. 2019 Oct.
Free article

Abstract

Fluorine-18 labeled hydroxyphenethylguanidines were recently developed in our laboratory as a new class of PET radiopharmaceuticals for quantifying regional cardiac sympathetic nerve density in heart disease patients. Studies of 4-[18 F]fluoro-m-hydroxyphenethylguanidine ([18 F]4F-MHPG) and 3-[18 F]fluoro-p-hydroxyphenethylguanidine ([18 F]3F-PHPG) in human subjects have shown that these radiotracers can be used to generate high-resolution maps of regional sympathetic nerve density using the Patlak graphical method. Previously, these compounds were synthesized using iodonium salt precursors, which provided sufficient radiochemical yields for on-site clinical PET studies. However, we were interested in exploring new methods that could offer significantly higher radiochemical yields. Spirocyclic iodonium ylide precursors have recently been established as an attractive new approach to radiofluorination of electron-rich aromatic compounds, offering several advantages over iodonium salt precursors. The goal of this study was to prepare a spirocyclic iodonium ylide precursor for synthesizing [18 F]4F-MHPG and evaluate its efficacy in production of this radiopharmaceutical. Under optimized automated reaction conditions, the iodonium ylide precursor provided radiochemical yields averaging 7.8% ± 1.4% (n = 8, EOS, not decay corrected), around threefold higher than those achieved previously using an iodonium salt precursor. With further optimization and scale-up, this approach could potentially support commercial distribution of [18 F]4F-MHPG to PET centers without on-site radiochemistry facilities.

Keywords: cardiac sympathetic innervation; hypervalent iodine; iodonium ylides; radiofluorination.

PubMed Disclaimer

References

REFERENCES

    1. Bengel FM, Thackeray JT. Altered cardiac innervation predisposes to ventricular arrhythmia: Targeted positron emission tomography identifies risk in ischemic cardiomyopathy. J Am Coll Cardiol. 2014;63(2):150-152.
    1. Jung YW, Jang KS, Gu G, et al. [18F]Fluoro-hydroxyphenethylguanidines: efficient synthesis and comparison of two structural isomers as radiotracers of cardiac sympathetic innervation. ACS Chem Nerosci. 2017;8(7):1530-1542.
    1. Raffel DM, Jung YW, Koeppe RA, et al. First-in-human studies of [18F]fluorohydroxyphenethylguanidines: positron emission tomography radiotracers for quantifying regional cardiac sympathetic nerve density. Circ Cardiovasc Imaging. 2018;11:e007965.
    1. Rotstein BH, Stephenson NA, Vasdev N, Liang SH. Spirocyclic hypervalent iodine (III)-mediated radiofluorination of non-activated and hindered aromatics. Nat Commun. 2014;5(1):4365-4371.
    1. Rotstein BH, Wang L, Liu RY, et al. Mechanistic studies and radiofluorination of structurally diverse pharmaceuticals with spirocyclic iodonium (III) ylides. Chem Sci. 2016;7(7):4407-4417.

LinkOut - more resources